Document Detail

The impact of drug transporters on adverse drug reaction.
MedLine Citation:
PMID:  23338766     Owner:  NLM     Status:  Publisher    
In this review, we have highlighted the adverse drug reaction mediated by transporters from two aspects: (1) competitive interactions between drug and drug/metabolite/endogenous substance mediated by transporters; (2) the expression/function change of transporter due to physiologic factors, disease, and drugs induction. It indicated that transporters exhibited a broad substrate specificity with a degree of overlap, which could change the pharmacokinetics of drugs and cause toxicity due to competition interactions among substrates. In addition, the expression and function of transporters were regulated by physiological conditions, pathological conditions, and drugs induction, which could cause adverse drug reaction and interindividual differences. Furthermore, one substrate was always medicated by several transporters and often subjected to metabolism by CYP enzymes, so we should be more aware of the increased plasma concentration of drugs caused by drug transporters as well as drug metabolizing enzymes synergistically, especially for drugs with narrow therapeutic window. In addition, the weightiness for one transporter to induce drugs plasma/tissue concentration change could be different in different condition. On the whole, transporters were corresponding with systemic/organs exposure of drug/metabolites/endogenous compounds. So understanding the expression and function in drug transporters will result in better strategies for optimal dosage regimen and reduce the risk for drug adverse reaction as well as adverse drug-drug interactions.
Yan Zhou; Guo-Qiang Zhang; Yu-Hui Wei; Jian-Ping Zhang; Guo-Rong Zhang; Jiang-Xia Ren; Hao-Gang Duan; Zhi Rao; Xin-An Wu
Related Documents :
23862726 - Novel pla microspheres with hydrophilic and bioadhesive surfaces for the controlled del...
24075886 - Ph sensitive laponite/doxorubicin/alginate nanohybrids with improved anticancer efficacy.
3271496 - A general procedure for assigning the 31p spectra of drug-oligonucleotide complexes.
24655046 - Improving brain drug targeting through exploitation of the nose-to-brain route: a physi...
10515296 - Discriminative effects of compound drug stimuli: a focus on attention.
2226476 - Correlation between pharmacokinetics, pharmacodynamics and efficacy of antibacterial ag...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-22
Journal Detail:
Title:  European journal of drug metabolism and pharmacokinetics     Volume:  -     ISSN:  0378-7966     ISO Abbreviation:  Eur J Drug Metab Pharmacokinet     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7608491     Medline TA:  Eur J Drug Metab Pharmacokinet     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Pharmacy, First Hospital of Lanzhou University, Lanzhou, 730000, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Synthesis and characterization of heterocyclic disilylchalcogenides.
Next Document:  Disposition and adjustment to chronic pain.